AstraZeneca 2Q Rev. $6.45B; Est. $6.33B

July 31 (Bloomberg) –- Bloomberg’s Caroline Hyde reports earnings for AstraZeneca, Britain’s second-biggest drug maker, which raised its full-year forecast. She speaks to Mark Barton and Ryan Chilcote on Bloomberg Television’s “Countdown.” (Source: Bloomberg)

Which Retailers Have the Best Deals on Toys?
04:13 - Guru Hariharan, Boomerang Commerce's chief executive officer, discusses the competitive environment in toy retail with Bloomberg's Scarlet Fu on "Bloomberg Markets." (Source: Bloomberg)
  • How to Play the Volatility in Stocks
  • The Politics of High Drug Prices
  • Is There a Cyclical Bear Market Underway?